Home > Resources > Whitepapers > 4 Pillars Pharma Distributors Can Stand On

4 Pillars Pharma Distributors Can Stand On

February 21, 2018

Despite a recent global economic downturn, the world pharmaceutical market is currently estimated to be valued at around $300 billion and rising, according to the World Health Organization (WHO). In a recent post, the WHO states that more than a third of the market is controlled by 10 large drug companies located in the US and Europe, and that, combined, the Americas, Europe, and Japan will comprise 85% of the market into the foreseeable future. According to the post, pharma companies spend one-third of their revenues on marketing, estimated at about double what is spent on research and development. To say competition in the pharmaceutical industry is fierce would be an understatement.

Spotlight

Bal Pharma Limited

Bal Pharma Limited, USD 30million company specializes in API, Intermediates and Finished Formulations. Having operations in more than 60 countries, the company possesses cGMP & has 4 state-of-the-art manufacturing facilities approved by various regulatory bodies.

OTHER WHITEPAPERS

Manufacturing High-Quality Capsule Products for Pharmaceutical and Nutraceutical Applications

whitePaper | October 25, 2022

To confirm the suitability of empty hard capsules for use in the application of quality-by-design (QbD) in the development and manufacturing of finished pharmaceutical products, the quality target product profile (QTPP) defined by eight critical quality attributes (CQA’s) was examined.